Maria Åhman Email

Quality Assurance Manager . Diamyd Medical

Current Roles

Employees:
47
Revenue:
$9.4M
About
Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development. Diamyd Medical develops the diabetes vaccine Diamyd®, an Antigen Based Therapy (ABT) based on the exclusively in-licensed GAD molecule. In-licensed technologies for GABA and Gliadin also have potential to become a key piece of the puzzle of a future solution to prevent, treat or cure autoimmune diabetes and other inflammation-related conditions. Diamyd Medical's share is traded on Nasdaq Stockholm First North, ticker DMYD B.
Diamyd Medical Address
Kungsgatan 29
Stockholm, null
SWE
Diamyd Medical Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.